Literature DB >> 28837972

Excessive Catecholamine Secretion and the Activation of the Renin-Angiotensin-Aldosterone-System in Patients with Pheochromocytoma: A Single Center Experience and Overview of the Literature.

Matthias Haase1, Till Dringenberg1, Stephanie Allelein1, Holger S Willenberg2, Matthias Schott1.   

Abstract

Catecholamines stimulate renin-secretion in the juxtaglomerular cells of the kidney and a number of case reports suggest an association between pheochromocytoma and activation of the RAAS. Therefore, it could be asked whether patients suffering from pheochromocytoma with high concentrations of circulating catecholamines present with oversecretion of renin and aldosterone. We identified twelve patients with excessive catecholamine secretion due to pheochromocytoma and compared them to a group of twelve patients with essential hypertension (EH) with regard to the activation of the renin-angiotensin-aldosterone-system (RAAS). The PubMed database was screened for studies that investigate the association between pheochromocytoma and activation of the RAAS. The plasma concentrations of metanephrines (19.9-fold) and normetanephrines (29.5-fold) were significantly higher in the pheochromocytoma group than in the EH group. Renin and aldosterone levels were 1.3-fold and 1.6-fold higher, respectively, as compared to the EH group, whereas the differences were not statistically significant. There was no significant correlation between plasma metanephrine or normetanephrine levels and the plasma renin concentration (rs=0.077, rs=0.049, respectively) in our patients. The data from our institution and from review of literature suggest that an association between pheochromocytoma in the context of high plasma catecholamine levels and activation of the RAAS is present. However, results have not been consistent. Thus, other causes of RAAS-activation should be considered also in the presence of pheochromocytoma or reinvestigation for aldosteronism should be offered to such patients after removal of the catecholamine-producing tumour. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28837972     DOI: 10.1055/s-0043-117179

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Targeted neurotransmitter metabolomics profiling of oleanolic acid in the treatment of spontaneously hypertensive rats.

Authors:  Ruixue Yu; Wenqing Yang; Dongmei Qi; Lili Gong; Chao Li; Yunlun Li; Haiqiang Jiang
Journal:  RSC Adv       Date:  2019-07-26       Impact factor: 4.036

2.  A case of pheochromocytoma presenting with cardiac manifestation: case report.

Authors:  Akbar Molaei; Vahideh Abarzadeh-Bairami; Seyyed-Reza Sadat-Ebrahimi
Journal:  BMC Pediatr       Date:  2020-06-17       Impact factor: 2.125

3.  Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases.

Authors:  Minmin Han; Xiaoming Cao; Changjian Zhao; Luyang Yang; Nan Yin; Pengliang Shen; Jin Zhang; Fei Gao; Yi Ren; Dong Liang; Jing Yang; Yi Zhang; Yunfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.